AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11281369 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 20 mg per day
Number of subjects: 9
Study 11281369 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone 30 mg per day
Number of subjects: 9
Study 8894364 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 51
Study 8894364 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 51
Study 1860325 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional operative tracheostomy
Number of subjects: 46
Study 1860325 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous tracheostomy
Number of subjects: 46
Study 6750118 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin capsules (50 mg for the first 5 days, 100 mg for the second 5 days)
Number of subjects: 45
Study 6750118 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin suppositories (50 mg for the first 5 days, 100 mg for the second 5 days)
Number of subjects: 45
Study 6750118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 30739584 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 70
Study 30739584 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 70
Study 30676671 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedtime music intervention
Number of subjects: 57
Study 30676671 — intervention group
Group type: COMPARATOR
Intervention: Audiobook control
Number of subjects: 57
Study 30676671 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 57
Study 30303192 — intervention group
Group type: EXPERIMENTAL
Intervention: Final Modified Tri‐Co system
Number of subjects: 1008
Study 30303192 — intervention group
Group type: COMPARATOR
Intervention: Tri‐Co scores
Number of subjects: 1008
Study 30303192 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified IDA scale
Number of subjects: 1008
Study 27654816 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine as a primary sedative (n = 138; 11%)
Number of subjects: 2449
Study 27654816 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine as a secondary sedative (n = 280; 23%)
Number of subjects: 2449
Study 27654816 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine as a periextubation agent (n = 178; 15%)
Number of subjects: 2449
Study 27654816 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 1,224)
Number of subjects: 2449
Study 24405345 — intervention group
Group type: EXPERIMENTAL
Intervention: Exam room teaching (n = 58)
Number of subjects: 126
Study 24405345 — intervention group
Group type: COMPARATOR
Intervention: Conference room teaching (n = 64)
Number of subjects: 126
Study 24405345 — intervention group
Group type: EXPERIMENTAL
Intervention: Exam room teaching
Number of subjects: 126
Study 23067918 — intervention group
Group type: EXPERIMENTAL
Intervention: Low ABI (≤0.90)
Number of subjects: 2368
Study 23067918 — intervention group
Group type: COMPARATOR
Intervention: High ABI (>1.3)
Number of subjects: 2368
Study 23067918 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncompressible ABI
Number of subjects: 2368
Study 23067918 — intervention group
Group type: COMPARATOR
Intervention: Normal ABI (0.91-1.3)
Number of subjects: 2368
Study 19592211 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventilator circuit change every 3 days
Number of subjects: 176
Study 19592211 — intervention group
Group type: COMPARATOR
Intervention: Ventilator circuit change every 7 days
Number of subjects: 176
Study 19592211 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day circuit change
Number of subjects: 176
Study 18990967 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 8, 16, or 32 microg administered once daily via Respimat SMI for 14 days
Number of subjects: 84
Study 18990967 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 0.02, 0.04, 0.08, 0.16, 0.28, or 0.40 microg applied as two drops to one eye
Number of subjects: 84
Study 18990967 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered in both studies
Number of subjects: 84
Study 15879427 — intervention group
Group type: EXPERIMENTAL
Intervention: CXCR3 activation by airway smooth muscle cultures
Number of subjects: 0
Study 15879427 — intervention group
Group type: EXPERIMENTAL
Intervention: CXCL10 expression in asthmatic airway smooth muscle
Number of subjects: 0
Study 15879427 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistology and enzyme-linked immunosorbent assay
Number of subjects: 0
Study 12794265 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 0
Study 12794265 — intervention group
Group type: EXPERIMENTAL
Intervention: LJP 394
Number of subjects: 0
Study 12794265 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-CD40L
Number of subjects: 0
Study 12794265 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal anti-IL-10
Number of subjects: 0
Study 12794265 — intervention group
Group type: EXPERIMENTAL
Intervention: Blocking peptides (LJP394)
Number of subjects: 0
Study 12794265 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIg
Number of subjects: 0
Study 12794265 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 0
Study 12794265 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem-cell restoration
Number of subjects: 0
Study 10584878 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of circulating tumour cells using MACS and FISH
Number of subjects: 48
Study 10584878 — intervention group
Group type: EXPERIMENTAL
Intervention: Detection of chromosomal aberrations in circulating tumour cells
Number of subjects: 48
Study 8981894 — intervention group
Group type: EXPERIMENTAL
Intervention: Transverse osteotomy with 0.062 Kirschner wire and tension band fixation
Number of subjects: 36
Study 8981894 — intervention group
Group type: EXPERIMENTAL
Intervention: Chevron osteotomy with 6.5‐mm cancellous lag screw and tension band fixation
Number of subjects: 36
Study 8981894 — intervention group
Group type: EXPERIMENTAL
Intervention: Oblique intraarticular osteotomy with 3.5‐mm cortical lag screw and tension band fixation
Number of subjects: 36
Study 8981894 — intervention group
Group type: COMPARATOR
Intervention: All techniques (Transverse, Chevron, Oblique)
Number of subjects: 36
Study 1464208 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg hyoscine-N-butylbromide
Number of subjects: 120
Study 1464208 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg hyoscine-N-butylbromide
Number of subjects: 120
Study 1464208 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg hyoscine-N-butylbromide
Number of subjects: 120
Study 6322992 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine
Number of subjects: 51
Study 6322992 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 31551219 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxycodone (O) alone postoperatively
Number of subjects: 90
Study 31551219 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with oxycodone (DO) postoperatively
Number of subjects: 90
Study 31551219 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (D) alone postoperatively
Number of subjects: 90
Study 29378622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile text messaging and community-based mentor mothers (cMMs)
Number of subjects: 0
Study 29378622 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based mentor mothers (cMMs) only
Number of subjects: 0
Study 29378622 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile text messaging only
Number of subjects: 0
Study 29378622 — intervention group
Group type: COMPARATOR
Intervention: Existing standard of care
Number of subjects: 0
Study 27585725 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive suggestions (verbal before and audiotaped during surgery)
Number of subjects: 95
Study 27585725 — intervention group
Group type: COMPARATOR
Intervention: Control group (no positive suggestions)
Number of subjects: 95
Study 24835382 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face structured conversation about end-of-life care options with family members.
Number of subjects: 0
Study 24835382 — intervention group
Group type: COMPARATOR
Intervention: Social contact via telephone (comparison group).
Number of subjects: 0
Study 23168756 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 145
Study 23168756 — intervention group
Group type: COMPARATOR
Intervention: Atosiban
Number of subjects: 145
Study 20205269 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimal weighted combination of pseudo-likelihood estimators
Number of subjects: 0
Study 20205269 — intervention group
Group type: COMPARATOR
Intervention: Independence working assumption pseudo-likelihood
Number of subjects: 0
Study 20205269 — intervention group
Group type: COMPARATOR
Intervention: Protective estimator pseudo-likelihood
Number of subjects: 0
Study 18609291 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydration scheme of 290 ml of water/m2
Number of subjects: 45
Study 18609291 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydration scheme of 580 ml of water/m2
Number of subjects: 45
Study 18609291 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous urinary drainage by catheter
Number of subjects: 45
Study 18609291 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase 2 (24 hours after Phase 1)
Number of subjects: 45
Study 16082646 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol/acetaminophen
Number of subjects: 313
Study 16082646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 313
Study 11858378 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemfibrozil (administered to 7 patients for 4 months)
Number of subjects: 12
Study 11858378 — intervention group
Group type: COMPARATOR
Intervention: Placebo (administered to 5 patients for 4 months)
Number of subjects: 12
Study 10360847 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG) - additional 20 mg oral morphine (10 mg at 12-h intervals)
Number of subjects: 60
Study 10360847 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyrone Group (DG) - 500 mg oral dipyrone at 6-h intervals
Number of subjects: 60
Study 10360847 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin Group (NG) - 5 mg nitroglycerin patch daily
Number of subjects: 60
Study 10360847 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine Group (KG) - 0.5 mg/kg oral ketamine at 12-h intervals
Number of subjects: 60
Study 7949225 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic patients with neurological disorders
Number of subjects: 0
Study 7949225 — intervention group
Group type: COMPARATOR
Intervention: Diabetic patients without neuropathy
Number of subjects: 0
Study 3345072 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphetamine
Number of subjects: 8
Study 3345072 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31935605 — intervention group
Group type: EXPERIMENTAL
Intervention: Bactiguard ETT
Number of subjects: 90
Study 31935605 — intervention group
Group type: COMPARATOR
Intervention: Taperguard ETT
Number of subjects: 90
Study 29568106 — intervention group
Group type: EXPERIMENTAL
Intervention: Children of university-educated mothers
Number of subjects: 12385
Study 29568106 — intervention group
Group type: EXPERIMENTAL
Intervention: Children of university-educated mothers at age 7
Number of subjects: 12385
Study 29568106 — intervention group
Group type: EXPERIMENTAL
Intervention: Children of university-educated mothers after controlling for parental BMI
Number of subjects: 12385
Study 28454528 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol (FP/SAL)
Number of subjects: 0
Study 28454528 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate (FP)
Number of subjects: 0
Study 25058803 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg methylprednisolone
Number of subjects: 59
Study 25058803 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 59
Study 22753629 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 156
Study 22753629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 156
Study 17668144 — intervention group
Group type: COMPARATOR
Intervention: TVT-O procedure
Number of subjects: 120
Study 17668144 — intervention group
Group type: EXPERIMENTAL
Intervention: Monarc procedure
Number of subjects: 120
Study 15715551 — intervention group
Group type: EXPERIMENTAL
Intervention: CeeOn Edge IOLs
Number of subjects: 116
Study 15715551 — intervention group
Group type: COMPARATOR
Intervention: SI40NB IOLs
Number of subjects: 116
Study 12816786 — intervention group
Group type: EXPERIMENTAL
Intervention: Atole (high-protein, moderate-energy drink)
Number of subjects: 263
Study 12816786 — intervention group
Group type: COMPARATOR
Intervention: Fresco (nonprotein, low-energy drink)
Number of subjects: 263
Study 12816786 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal nutritional supplementation
Number of subjects: 263
Study 10484799 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused asthma intervention
Number of subjects: 1033
Study 10484799 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1033
Study 8839554 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole, 20 mg once a day
Number of subjects: 182
Study 8839554 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 1 tablet twice a day
Number of subjects: 182
Study 8839554 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol, 400 micrograms twice a day
Number of subjects: 182
Study 1503250 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-uterine insemination with washed sperm
Number of subjects: 41
Study 1503250 — intervention group
Group type: COMPARATOR
Intervention: Intra-uterine insemination with split ejaculate
Number of subjects: 41
Study 1503250 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-uterine insemination with washed sperm (cervical infertility)
Number of subjects: 41
Study 1503250 — intervention group
Group type: COMPARATOR
Intervention: Intra-uterine insemination with split ejaculate (cervical infertility)
Number of subjects: 41
Study 6389394 — intervention group
Group type: EXPERIMENTAL
Intervention: Antimicrobial agents (antibiotics)
Number of subjects: 0
Study 6389394 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 0
Study 31464020 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual sphygmomanometer (MS) in sinus rhythm (SR)
Number of subjects: 100
Study 31464020 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated sphygmomanometer (AS) in sinus rhythm (SR)
Number of subjects: 100
Study 31464020 — intervention group
Group type: EXPERIMENTAL
Intervention: PulseCor R6.5 (PC) in sinus rhythm (SR)
Number of subjects: 100
Study 31464020 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual sphygmomanometer (MS) in atrial fibrillation (AF)
Number of subjects: 100
Study 31464020 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated sphygmomanometer (AS) in atrial fibrillation (AF)
Number of subjects: 100
Study 31464020 — intervention group
Group type: EXPERIMENTAL
Intervention: PulseCor R6.5 (PC) in atrial fibrillation (AF)
Number of subjects: 100
Study 30113959 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-week Iyengar yoga intervention
Number of subjects: 18
Study 26742176 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuji II LC resin‐modified glass ionomer (RMGI)
Number of subjects: 90
Study 26742176 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonalin
Number of subjects: 90
Study 26742176 — intervention group
Group type: EXPERIMENTAL
Intervention: IRM
Number of subjects: 90
Study 26742176 — intervention group
Group type: EXPERIMENTAL
Intervention: Coltosol
Number of subjects: 90
Study 26742176 — intervention group
Group type: COMPARATOR
Intervention: Not restored (negative control)
Number of subjects: 90
Study 26742176 — intervention group
Group type: COMPARATOR
Intervention: Intact teeth (positive control)
Number of subjects: 90
Study 24215940 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic prostatectomy
Number of subjects: 0
Study 24215940 — intervention group
Group type: COMPARATOR
Intervention: Open prostatectomy
Number of subjects: 0
Study 22504223 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (400 kcal/session, 5 days/week, for 10 months)
Number of subjects: 141
Study 22504223 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (600 kcal/session, 5 days/week, for 10 months)
Number of subjects: 141
Study 22504223 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control group
Number of subjects: 141
Study 22504223 — intervention group
Group type: EXPERIMENTAL
Intervention: Both exercise groups
Number of subjects: 141
Study 19561460 — intervention group
Group type: EXPERIMENTAL
Intervention: Early endoscopic retrograde cholangiopancreatography (ERCP)
Number of subjects: 153
Study 19561460 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 153
Study 17587396 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (45 mg/day)
Number of subjects: 97
Study 15579728 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized polyphenol extract
Number of subjects: 0
Study 15579728 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (normal subjects)
Number of subjects: 0
Study 12021585 — intervention group
Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 46
Study 9808599 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive medical therapy
Number of subjects: 44
Study 9808599 — intervention group
Group type: COMPARATOR
Intervention: Coronary angioplasty (PTCA)
Number of subjects: 44
Study 7608823 — intervention group
Group type: EXPERIMENTAL
Intervention: 2'-3' dideoxyinosine (ddI)
Number of subjects: 34
Study 1971320 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg mifepristone, given orally 48 h before surgery
Number of subjects: 60
Study 1971320 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 7017139 — intervention group
Group type: EXPERIMENTAL
Intervention: Anal dilator used after anal stretch
Number of subjects: 89
Study 7017139 — intervention group
Group type: COMPARATOR
Intervention: Anal stretch alone (Control)
Number of subjects: 89
Study 30451757 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxymetazoline 1.0%
Number of subjects: 19
Study 30451757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 28118423 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsaicin (30 μL of 5% capsaicin)
Number of subjects: 12
Study 28118423 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (control)
Number of subjects: 12
Study 26123356 — intervention group
Group type: EXPERIMENTAL
Intervention: HUC‐MSCs
Number of subjects: 79
Study 26123356 — intervention group
Group type: EXPERIMENTAL
Intervention: BM‐MNCs
Number of subjects: 79
Study 26123356 — intervention group
Group type: COMPARATOR
Intervention: CABG alone (Control)
Number of subjects: 79
Study 25150401 — intervention group
Group type: EXPERIMENTAL
Intervention: AA attendance during treatment (12 weeks of outpatient treatment)
Number of subjects: 1726
Study 21676165 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (600 mg)
Number of subjects: 120
Study 21676165 — intervention group
Group type: COMPARATOR
Intervention: Active placebo (12.5 mg diphenhydramine)
Number of subjects: 120
Study 19112061 — intervention group
Group type: EXPERIMENTAL
Intervention: Plain articaine 50 mg
Number of subjects: 72
Study 19112061 — intervention group
Group type: COMPARATOR
Intervention: Plain prilocaine 50 mg
Number of subjects: 72
Study 17977159 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS group
Number of subjects: 31
Study 17977159 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 31
Study 16680610 — intervention group
Group type: EXPERIMENTAL
Intervention: ROB‐ML (robotics and motor learning)
Number of subjects: 12
Study 16680610 — intervention group
Group type: EXPERIMENTAL
Intervention: FNS‐ML (functional neuromuscular stimulation and motor learning)
Number of subjects: 12
Study 12181997 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic field stimulation using VIOFOR JPS
Number of subjects: 76
Study 12181997 — intervention group
Group type: COMPARATOR
Intervention: Control group (no magnetic stimulation)
Number of subjects: 76
Study 9814448 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticosteroid therapy (methylprednisolone, 1 g i.v. for 2 consecutive days a week for 6 weeks)
Number of subjects: 10
Study 7657044 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha‐interferon (IFN) alfa‐2b (6 MU 3 times weekly for the first month and 3 MU for the next 11 months)
Number of subjects: 63
Study 7657044 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha‐interferon (IFN)
Number of subjects: 63
Study 7657044 — intervention group
Group type: COMPARATOR
Intervention: no treatment (control group)
Number of subjects: 63
Study 2511695 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN)
Number of subjects: 0
Study 2511695 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide-2-mononitrate (IS-2-MN)
Number of subjects: 0
Study 2511695 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (IS-5-MN)
Number of subjects: 0
Study 2511695 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 0
Study 8070 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmefamol 200 mug
Number of subjects: 0
Study 8070 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 200 mug
Number of subjects: 0
Study 31056441 — intervention group
Group type: EXPERIMENTAL
Intervention: GLPG2222 200 mg (FLAMINGO)
Number of subjects: 96
Study 31056441 — intervention group
Group type: EXPERIMENTAL
Intervention: GLPG2222 300 mg (ALBATROSS)
Number of subjects: 96
Study 31056441 — intervention group
Group type: COMPARATOR
Intervention: Placebo (FLAMINGO)
Number of subjects: 96
Study 31056441 — intervention group
Group type: COMPARATOR
Intervention: Placebo (ALBATROSS)
Number of subjects: 96
Study 31056441 — intervention group
Group type: EXPERIMENTAL
Intervention: GLPG2222
Number of subjects: 96
Study 27942999 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm-based treatments (AT)
Number of subjects: 100
Study 27942999 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 100